VECTORMUNE vaccines are the next generation of poultry vaccines. These vector vaccines provide producers with all of the benefits of modified live vaccines without any of the disadvantages. VECTORMUNE vaccines are genetically engineered to express key protective antigens against virulent poultry diseases including Newcastle Disease, Marek’s Disease, Fowl Pox, Gumboro, Avian Influenza, Avian Encephalomyelitis and Mycoplasma.
Ceva received the first USDA license for a poultry vaccine against S. enteritidis. Introduced in 1992, LAYERMUNE SE has been instrumental in earning Ceva the #1 ranking in salmonella vaccines in the U.S. With the concern of S. enteritidis to human health, the proven efficacy of LAYERMUNE SE quickly expanded Ceva’s worldwide reach.
country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the Ceva Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorized persons.